Maintenance ECT for hard-to-treat schizophrenia
Part of Mental health clinical trials.
This trial tests if regular electroconvulsive therapy (ECT) can help people whose schizophrenia has not improved with clozapine or who cannot take clozapine. Researchers will see if maintenance ECT helps prevent symptoms from returning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have schizophrenia that has not improved with clozapine, or you cannot take clozapine due to side effects or medical reasons.
- You currently have moderate to severe symptoms, as measured by a standard symptom scale.
- You are not diagnosed with dementia, a severe substance use disorder, an affective disorder (like bipolar or depression with psychosis), or a personality disorder.
- You can read and write in German.
- You are not pregnant or breastfeeding.
- You do not have a medical condition that makes ECT unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of brain stimulation called magnetic seizure therapy (MST) for people with schizophrenia who haven't gotten better with standard medicines. The goal is to see if MST can help reduce symptoms like hallucinations or confusion.
This trial tests a type of brain stimulation called TMS to see if it can change brain connections that may be linked to symptoms. It might help people with schizophrenia or schizoaffective disorder who are stable on their current medications.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This trial tests an accelerated form of transcranial magnetic stimulation (TMS) for people with treatment-resistant depression who have been referred for ECT. It aims to offer a non-invasive, less intensive alternative with fewer side effects.
This study compares maintenance electroconvulsive therapy (ECT) to the medication aripiprazole for people whose schizophrenia has not improved enough with clozapine. The goal is to see which approach works better for continued treatment.
This study looks at “neural biomarkers,” or brain-measurement signals, to see who is most likely to benefit from electroconvulsive therapy (ECT). It focuses on people with certain active psychosis symptoms and specific mental health diagnoses who have tried antipsychotic medication without enough improvement.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.